Rani Therapeutics Inc.

NASDAQ: RANI · Real-Time Price · USD
0.56
0.01 (1.82%)
At close: Aug 18, 2025, 3:37 PM

Rani Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-46.93M -42.51M -42.73M -34.11M -39.72M -51.58M -60.93M -71.17M -69.05M -66.35M -63.34M -59.31M -71.8M -61.32M -53.09M -45.54M -19.72M -16.95M
Depreciation & Amortization
1.02M 1.03M 1.03M 989K 948K 882K 822K 769K 692K 625K 548K 487K 466K 472K 497K 526K 550K 572K
Stock-Based Compensation
15.25M 16.09M 16.03M 16.53M 17.45M 18.46M 19.01M 19.02M 18.46M 17.29M 15.78M 14.45M 28.74M 25.05M 22.59M 19.43M 735K 453K
Other Working Capital
-2.69M -2.22M -1.25M -2.66M -2.21M -920K -1.54M -617K -74K -491K 346K 454K -1.08M -3.05M -3.97M -3.47M 1.86M 2.12M
Other Non-Cash Items
201K -7.17M -9.28M -14.72M -15.07M -8.06M -1.25M -92K -390K -548K -10K 338K 302K 199K 109K 806K 889K 160K
Deferred Income Tax
n/a n/a n/a -5.6M -6.21M -6.75M -6.75M -1.15M -543K n/a n/a n/a 785K 855K 1.07M 1.07M 286K 216K
Change in Working Capital
-544K -1.68M -544K -2.4M -2.61M -1.43M -2.14M -763K -452K -330K 509K 700K -752K -2.81M -3.43M -3.79M 1.56M 2.66M
Operating Cash Flow
-31.01M -34.24M -35.5M -39.32M -45.21M -48.48M -51.24M -53.39M -51.28M -49.31M -46.52M -43.34M -42.26M -37.56M -32.24M -27.5M -15.71M -12.89M
Capital Expenditures
-244K -301K -268K -404K -758K -999K -1.23M -1.59M -1.57M -1.61M -1.62M -1.36M -904K -661K -506K -491K -491K -399K
Cash Acquisitions
n/a n/a n/a -13.44K -25.59K -26.72K -26.72K -71.75M -71.74M -71.74M -71.74M n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-39.52M -51.09M -58.41M -50.07M -42.38M -64.67M -73.26M -66.78M -126.32M -92.45M -73.82M -70.89M n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
65.75M 78.2M 77.55M 80.1M 84.9M 101.7M 104.35M 84.5M 61M 26M 3M n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
948K 940K 940K 953.44K 25.59K 26.72K 26.72K 71.75M 71.67M 71.67M 71.67M -70.89K n/a n/a n/a n/a n/a n/a
Investing Cash Flow
26.93M 27.74M 19.81M 30.56M 41.77M 36.03M 29.86M 16.13M -66.89M -68.06M -72.44M -72.25M -904K -661K -506K -491K -491K -399K
Debt Repayment
-12.5M -8.75M -5M -1.25M n/a n/a n/a 14.9M 14.9M 14.9M 14.9M n/a n/a n/a n/a n/a 2.78M 2.78M
Common Stock Repurchased
46K n/a n/a n/a n/a -9 -9 -9 -635 -626 -626 -626 n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-55K -71K -48K -38K -53K 51K 59K 30K 14.14M 14.11M 14.1M 14.13M 71.6M 69.97M 71.4M 71.55M 3K 2.84M
Financial Cash Flow
9.78M 9.73M 13.59M 8.06M 407K 266.08K 153.08K 14.93M 28.96M 29.01M 29M 13.56M 71.03M 69.39M 77.15M 146.36M 77.59M 80.43M
Net Cash Flow
5.7M 3.23M -2.1M -695K -3.04M -12.11M -21.14M -22.25M -89.13M -88.36M -89.95M -102.02M 27.87M 31.18M 44.4M 118.38M 61.4M 67.15M
Free Cash Flow
-31.25M -34.54M -35.76M -39.72M -45.97M -49.48M -52.47M -54.98M -52.85M -50.92M -48.13M -44.7M -43.16M -38.22M -32.75M -27.99M -16.2M -13.29M